BIO-key Expands Product Line and Market Reach with Launch

WALL, NJ, September 27, 2021 (GLOBE NEWSWIRE) – BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of identity and access management (IAM) solutions integrating identity-linked biometrics, today announced the availability of a brand new range of BIO-key cryptographic security keys that comply with the FIDO2 authentication standard. FIDO2 is the industry’s “something you have” authentication standard that addresses the global password problem, standardizing how applications confirm a person’s possession of a cryptographic hardware key. BIO-key FIDO Keys, a range of affordable FIDO2 security keys, offer USB-A, USB-C, NFC and iOS Lightning compatibility as well as FIPS 140-2 certified options with biometric verification on the device , all backed by BIO- key’s US-based support and integration team.

BIO-key FIDO keys provide unique login credentials on each website and never leave the user’s possession. This security model eliminates the risk of phishing, all forms of password theft and replay attacks. Combined as a factor option with BIO-key’s ‘who you are’ biometrics, these new FIDO2 security keys give BIO-key customers complete flexibility to choose how they leverage power of biometrics in strong authentication scenarios. They can choose either a FIDO2 biometric security key stored on the device or a centrally secured remote biometric authenticator using BIO-key’s identity-linked biometrics. Both options are consistent with the FIDO Alliance Authenticator Lifecycle Management for IT Administrators white paper.

BIO-key’s FIDO keys have many secure password-less workflow applications and are fully supported by BIO-key’s award-winning PortalGuard IAM platform, extending its more than 16 supported authentication methods. Support for multi-factor authentication (MFA), single sign-on (SSO), and self-service password reset. PortalGuard is available in IDaaS or on-premises configurations. FIDO keys are also accepted for Windows 10 and Azure sign-in, as well as the hundreds of FIDO2-ready WebAuthn apps and services apps.

“Customers want choices, not limits, when implementing multi-factor authentication for their staff and users,” said Michael DePasquale, president and CEO of BIO-key. “The addition of new FIDO2 security keys to our suite of solutions expands the already unmatched range of strong authentication methods that we make available to our customers, offering them a competitively priced alternative to hardware suppliers of choice. unique, ”continued DePasquale.

More information and detailed specifications for FIDO keys are available on the BIO-key website.

About BIO-key International, Inc. (
BIO-key has over two decades of expertise in providing authentication technologies for thousands of organizations and millions of users and is revolutionizing authentication with multi-factor identity and access management (IAM) solutions and biometric, including its PortalGuard IAM solution, which provides convenient and secure access to high-value devices, information, applications and transactions. BIO-key’s patented software and hardware solutions with industry-leading biometric capabilities enable large-scale on-premises and Identity-as-a-Service (IDaaS) solutions as well as customized enterprise and cloud solutions.

BIO-key Safe Harbor Declaration
All statements in this press release other than statements of historical fact are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate”, “plan”, “intend”, “expect”, “anticipate”, “believe”, and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on the beliefs of management, as well as assumptions made by management and information currently available to management in accordance with the “safe harbor” provisions of the Law. These statements do not constitute guarantees of performance or future events and are subject to risks and uncertainties that could cause actual results to differ materially from those included or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, our history of loss and limited income; our ability to raise additional capital; our ability to protect our intellectual property; changes in trading conditions; changes in our sales strategy and product development plans; changes in the market; ongoing services from our management team; security failures; competition in the biometric technology industry; market acceptance of biometric products in general and our products under development; our ability to execute and deliver contracts in Africa; our ability to grow in Asia, Africa and other foreign markets; the duration and severity of the current COVID-19 coronavirus pandemic and its effects on our business operations, sales cycles, people and the geographic markets in which we operate; delays in product development and statements of assumption underlying all of the foregoing as well as other factors set out under the heading see “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of writing. forward-looking statements, whether as a result of new information, future events or otherwise. In addition, there may be other factors of which the Company is not currently aware that may affect the matters addressed in the forward-looking statements and may also cause actual results to differ in particular, the consequences of the coronavirus outbreak. on economic conditions and the industry in general, as well as on the financial position and operations The results of our Company, in particular, have been significant, change rapidly and cannot be predicted.

Get involved with BIO-key:

Facebook – Company:
LinkedIn – Company:
Twitter – Company: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

BIO-key media contact:
Erin knapp
Communication of the case

Investor contacts:
William Jones, David Collins
IR Catalyst

Source link

About Marion Browning

Check Also

What can hotel companies do to mitigate the effects of PSD2?

In September 2019, despite calls from many players in the hospitality and travel (H&T) sectors …

Leave a Reply

Your email address will not be published. Required fields are marked *